GSK
773 hedge funds and large institutions have $11.3B invested in GSK in 2021 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 299 increasing their positions, 292 reducing their positions, and 89 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
773
Holders Change
-44
Holders Change %
-5.39%
% of All Funds
13.61%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.18%
New
54
Increased
299
Reduced
292
Closed
89
Calls
$152M
Puts
$116M
Net Calls
+$36M
Net Calls Change
+$29.4M
Top Buyers
| 1 |
Dodge & Cox
San Francisco,
California
|
+$893M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$251M |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
+$124M |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$81.1M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$76.7M |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$197M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
-$196M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$177M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$161M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$78.9M |